{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T01:40:32Z","timestamp":1729474832736,"version":"3.27.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to investigate fatty acids, lipid mediator levels, and the desaturase index rates on different acute coronary syndrome types and their possible relationship with routine lipid parameters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study included 81 patients with myocardial infarction (MI), 20 patients with unstable angina pectoris, and 31 healthy people. Fatty acids, CD59, lipoxin A4, 8-isoprostane, serum lipids, albumin, C-reactive protein (CRP), and high sensitive troponin levels were measured in all participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>When the fatty acid groups were evaluated as a ratio of albumin, MUFA\/albumin and SFA\/albumin ratios were significantly higher in the MI group compared to the control group. Although CD59 and lipoxin A4 levels were higher in the control group, there was no significant differences between the groups. When lipoxin A4\/CRP and CD59\/CRP ratios were evaluated, the results were significantly lower than those in the control group.\u00a0<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lipid mediators may be useful in treating atherosclerosis by contributing to the resolution of inflammation.<\/jats:p><\/jats:sec>","DOI":"10.1093\/labmed\/lmad042","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T19:20:39Z","timestamp":1686597639000},"page":"88-95","source":"Crossref","is-referenced-by-count":0,"title":["Can lipid mediators and free fatty acids guide acute coronary syndrome diagnosis and treatment?"],"prefix":"10.1093","volume":"55","author":[{"given":"Gulbahar","family":"Uzun","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslihan","family":"Unal","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Basarici","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murathan","family":"Kucuk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Donmez","sequence":"additional","affiliation":[{"name":"Department of Public Health, and, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cahit","family":"Nacitarhan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebahat","family":"\u00d6zdem","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Akdeniz University Medical Faculty , Antalya , Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"article-title":"Association for Fighting Hypertension. X. Ege Hypertension Week","year":"2008","author":"Akilli","key":"2024010613074675900_CIT0001"},{"issue":"5","key":"2024010613074675900_CIT0002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5551\/jat.7591","article-title":"Inflammation and the development of atherosclerosis","volume":"18","author":"Mizuno","year":"2011","journal-title":"J Atheroscler Thromb."},{"issue":"5","key":"2024010613074675900_CIT0003","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.arcmed.2011.07.004","article-title":"Long-term prognostic value of myeloperoxidase on acute coronary syndrome: a meta-analysis","volume":"42","author":"Chen","year":"2011","journal-title":"Arch Med Res."},{"issue":"10","key":"2024010613074675900_CIT0004","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"issue":"6","key":"2024010613074675900_CIT0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory-pro-resolving mediators and their receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"Curr Top Med Chem."},{"issue":"3","key":"2024010613074675900_CIT0006","first-page":"121","article-title":"Properties, effects and relationships of omega-3 and omega-6 fatty acids with cardiovascular diseases","volume":"12","author":"Konukoglu","year":"2008","journal-title":"Turk Aile Hek Derg."},{"issue":"2","key":"2024010613074675900_CIT0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00380-010-0038-8","article-title":"Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction","volume":"26","author":"Ueeda","year":"2011","journal-title":"Heart Vessels."},{"issue":"6","key":"2024010613074675900_CIT0008","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bcp.2008.10.020","article-title":"Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention","volume":"77","author":"Russo","year":"2009","journal-title":"Biochem Pharmacol."},{"key":"2024010613074675900_CIT0009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-511X-7-37","article-title":"Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules","volume":"7","author":"Das","year":"2008","journal-title":"Lipids Health Dis."},{"key":"2024010613074675900_CIT0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12944-015-0135-x","article-title":"The association of cardiovascular risk factors with saturated fatty acids and fatty acid desaturase indices in erythrocyte in middle-aged Korean adults","volume":"14","author":"Kim","year":"2015","journal-title":"Lipids Health Dis."},{"key":"2024010613074675900_CIT0011","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vph.2016.04.001","article-title":"MicroRNAs as circulating biomarkers in acute coronary syndromes: a review","volume":"81","author":"Ahlin","year":"2016","journal-title":"Vascul Pharmacol."},{"issue":"4-6","key":"2024010613074675900_CIT0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.plefa.2010.02.003","article-title":"Resolvins and protectins: natural pharmacophores for resolution biology","volume":"82","author":"Levy","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"issue":"3-5","key":"2024010613074675900_CIT0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.plefa.2008.09.012","article-title":"Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators","volume":"79","author":"Serhan","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"issue":"1-2","key":"2024010613074675900_CIT0014","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2013.09.025","article-title":"at . Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-\/-) mice","volume":"156","author":"Li","year":"2013","journal-title":"Immunol Lett."},{"issue":"22","key":"2024010613074675900_CIT0015","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.3889\/oamjms.2019.526","article-title":"Atherosclerosis prediction with high sensitivity c-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia","volume":"7","author":"Swastini","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"issue":"7","key":"2024010613074675900_CIT0016","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199408183310709","article-title":"Inflammation and coronary heart disease","volume":"331","author":"Alexander","year":"1994","journal-title":"N Engl J Med."},{"key":"2024010613074675900_CIT0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-511X-10-76","article-title":"Lipoxins as biomarkers of lupus and other inflammatory conditions","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis."},{"key":"2024010613074675900_CIT0018","first-page":"57","article-title":"Lipid peroxidation, isoprostanes and vascular damage","volume":"58","author":"Minuz","year":"2006","journal-title":"Pharmacol Rep."},{"issue":"35","key":"2024010613074675900_CIT0019","doi-asserted-by":"crossref","first-page":"23636","DOI":"10.1074\/jbc.M109.024075","article-title":"Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation","volume":"284","author":"Song","year":"2009","journal-title":"J Biol Chem."},{"key":"2024010613074675900_CIT0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/0471140856.tx1214s39","article-title":"Measurement of isoprostanes as markers of oxidative stress in neuronal tissue","volume":"39","author":"Milatovic","year":"2009","journal-title":"Curr Protoc Toxicol."},{"issue":"1-2","key":"2024010613074675900_CIT0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.20452\/pamw.871","article-title":"Elevated levels of 8-iso-prostaglandin F2alpha in acute coronary syndromes are associated with systemic and local platelet activation","volume":"120","author":"Szuldrzynski","year":"2010","journal-title":"Pol Arch Med Wewn."},{"issue":"1","key":"2024010613074675900_CIT0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1079\/PNS2003314","article-title":"Lipid metabolism in women","volume":"63","author":"Williams","year":"2004","journal-title":"Proc Nutr Soc."},{"issue":"8","key":"2024010613074675900_CIT0023","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00380-015-0721-x","article-title":"Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome","volume":"31","author":"Sakamoto","year":"2016","journal-title":"Heart Vessels."},{"issue":"1","key":"2024010613074675900_CIT0024","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12872-016-0299-y","article-title":"Association between the docosahexaenoic acid to arachidonic acid ratio and acute coronary syndrome: a multicenter observational study","volume":"16","author":"Nishizaki","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"issue":"4","key":"2024010613074675900_CIT0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/10715762.2014.883071","article-title":"High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the cardiovascular risk in young Finns study","volume":"48","author":"Kaikkonen","year":"2014","journal-title":"Free Radic Res."},{"key":"2024010613074675900_CIT0026","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM199711203372102","article-title":"Dietary fat intake and the risk of coronary heart disease in women","volume":"337","author":"Hu","year":"1997","journal-title":"N Engl J Med."},{"key":"2024010613074675900_CIT0027","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J."},{"key":"2024010613074675900_CIT0028","doi-asserted-by":"crossref","first-page":"690953","DOI":"10.1155\/2014\/690953","article-title":"Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque","volume":"2014","author":"Lepedda","year":"2014","journal-title":"Oxid Med Cell Longev."},{"key":"2024010613074675900_CIT0029","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/oxfordjournals.aje.a116030","article-title":"The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial","volume":"134","author":"Kuller","year":"1991","journal-title":"Am J Epidemiol."},{"key":"2024010613074675900_CIT0030","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA."},{"issue":"6","key":"2024010613074675900_CIT0031","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1002\/ehf2.13640","article-title":"Prognostic impact of follow-up serum albumin after acute myocardial infarction","volume":"8","author":"Yoshioka","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024010613074675900_CIT0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-07320-0_1","article-title":"Oxidative stress and inflammation in non-communicable diseases-molecular mechanisms and perspectives in therapeutics","volume":"824","author":"Camps","year":"2014","journal-title":"Adv Exp Med Biol."},{"issue":"9","key":"2024010613074675900_CIT0033","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.nutres.2014.08.005","article-title":"Serum phospholipid monounsaturated fatty acid composition and delta-9-desaturase activity are associated with early alteration of fasting glycemic status","volume":"34","author":"Cho","year":"2014","journal-title":"Nutr Res."},{"key":"2024010613074675900_CIT0034","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.3390\/ijms23105680","article-title":"Cardiovascular biomarkers: lessons of the past and prospects for the future","volume":"23","author":"Omran","year":"2022","journal-title":"Int J Mol Sci ."},{"key":"2024010613074675900_CIT0035","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J."},{"key":"2024010613074675900_CIT0036","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the Redefinition of Myocardial Infarction","volume":"36","author":"The Joint European Society of Cardiology\/American College of Cardiology Committee","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"2024010613074675900_CIT0037","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"2024010613074675900_CIT0038","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","article-title":"Recommendations for the use of cardiac troponin measurement in acute cardiac care","volume":"31","author":"Thygesen","year":"2010","journal-title":"Eur Heart J."},{"key":"2024010613074675900_CIT0039","first-page":"623404","article-title":"Cardiac troponin level elevations not related to acute coronary syndromes. Troponin elevation in coronary vs. non-coronary disease","volume":"1032","author":"Giannitsis","year":"20132011","journal-title":"Nat Rev Cardiol Eur Heart J"},{"key":"2024010613074675900_CIT0040","first-page":"1","article-title":"Cardiac natriuretic peptides","volume-title":"Endocrinology of the Heart in Health and Disease: Integrated, Cellular, and Molecular Endocrinology of the Heart","author":"Pemberton","year":"2016"},{"issue":"22","key":"2024010613074675900_CIT0041","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"MORGAM Project. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/55\/1\/88\/55121239\/lmad042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/labmed\/article-pdf\/55\/1\/88\/55121239\/lmad042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T01:19:43Z","timestamp":1729473583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/55\/1\/88\/7194608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,12]]},"published-print":{"date-parts":[[2024,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmad042","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"type":"print","value":"0007-5027"},{"type":"electronic","value":"1943-7730"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,6,12]]}}}